Clinical Trial Update: Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating long-term safety, tolerability, and clinical effects of inhaled iloprost in patients with primary or secondary pulmonary hyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Ventavis (iloprost)

Snippet

Sponsor: Bayer | Conditions: Hypertension, Pulmonary | Phase 2 | Status: COMPLETED